Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Rare Disease Registries Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The rare disease registries market size has seen swift expansion in recent years. It will grow from $1.62 billion in 2025 to $1.82 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The expansion observed historically stems from factors such as increasing awareness of rare diseases, a rise in clinical research activities, the development of hospital and population-based registries, regulatory frameworks supporting patient data collection, and the limited availability of structured patient data.
The rare disease registries market size is anticipated to undergo significant expansion in the coming years. It will grow to $2.96 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. This growth during the forecast period is propelled by factors such as the adoption of AI-driven registry solutions, the integration of genomic and omics data, the expansion of personalized medicine initiatives, investment in cloud-based interoperable platforms, and enhanced patient engagement and data sharing. Prominent trends for the forecast period encompass real-time patient data collection, integration with electronic health records (EHR), advanced data analytics specific to rare diseases, optimization of patient recruitment and retention, and the implementation of interoperable registry platforms.
Get A Free Sample Report With In-Depth Market Insights:
Rare Disease Registries Market Growth Drivers: What’s Behind The Acceleration?
The rare disease registries market is anticipated to expand over the forecast period, primarily driven by increasing government initiatives and financial assistance. Such government initiatives and funding support encompass public-sector endeavors and investments aimed at strengthening healthcare infrastructure, fostering innovation, and improving service delivery. The rising public funding signifies efforts to enhance data-informed policymaking, optimize resource distribution, and improve outcomes for underserved patient populations, including individuals affected by rare diseases. Rare disease registries play a crucial role in achieving these objectives by aggregating comprehensive patient data that guides policy decisions, facilitates targeted funding allocation, and enables the development and evaluation of effective healthcare and research programs. For instance, in February 2025, the UK government’s central executive authority allocated approximately £26 billion ($35 billion) over two years to bolster the health and care system, reinforcing investment in data infrastructure and population health initiatives. Thus, the growing government initiatives and funding support are propelling the expansion of the rare disease registries market.
Rare Disease Registries Market Segment Analysis And Revenue Potential
The rare disease registries market covered in this report is segmented –
1) By Type: Product Registries, Health Services Registries, Disease Registries
2) By Database Type: Population-based, Hospital-based
3) By Software: Standalone, Integrated
4) By Function: Data Collection, Data Analysis, Patient Recruitment, Other Functions
5) By End-User: Pharmaceutical Companies, Research Organizations, Hospitals, Government Agencies, Other End-Users
Subsegments:
1) By Product Registries: Drug Product Registries, Biologic Product Registries, Medical Device Registries, Gene Therapy Product Registries
2) By Health Services Registries: Hospital Based Registries, Clinic Based Registries, National Health Program Registries, Insurance Claims Registries
3) By Disease Registries: Genetic Disorder Registries, Metabolic Disorder Registries, Neurological Disorder Registries, Oncology Rare Disease Registries
Rare Disease Registries Market Trends: What’s Defining The Industry’s Next Phase?
Major companies operating within the rare disease registries market are concentrating on developing sophisticated products, such as an AI-enabled patient registry infrastructure, to enhance real-time data capture, patient monitoring, and research insights across rare diseases. An AI-enabled patient registry infrastructure denotes registry systems that utilize artificial intelligence to efficiently process, analyze, and interpret large-scale patient and clinical data, thereby facilitating predictive analytics, natural history modeling, and real-world evidence generation. For instance, in May 2024, the National Organization for Rare Disorders (NORD), a US-based non-profit advocacy organization dedicated to individuals with rare diseases and the organizations that serve them, introduced the inaugural Canadian rare disease patient registries on its IAMRARE platform for phenylketonuria (PKU) and mucopolysaccharidoses (MPS). This initiative enables real-time cooperative data collection, supports multiple languages and regional consent requirements, and provides valuable insights for clinical trial eligibility, tracking disease progression, and evaluating treatments.
Rare Disease Registries Market Key Participants And Competitive Landscape
Major companies operating in the rare disease registries market are disease registries market are Deloitte Touche Tohmatsu Limited, International Business Machines Corporation, Oracle Corporation, BC Platforms Ltd., IQVIA Holdings Inc., ICON plc, Veeva Systems Inc., Alira Health Inc., Phastar Ltd., HealthVerity Inc., OM1 Inc., Synapse Laboratory, Castor EDC, RedCap Cloud, Within3 Inc., Sage Bionetworks, National Organization for Rare Disorders Inc., RTI Health Solutions, ArborMetrix Inc., Evado Clinical Systems Ltd., ClinCapture LLC, Global Vision Technologies Inc., Genetic Alliance UK, Pulse Infoframe.
View The Full Rare Disease Registries Market Report:
Rare Disease Registries Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the rare disease registries market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare disease registries market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
